Heavily invested in industry leading research
Research reports published in 2022
Small-, mid- and large-cap stocks under coverage
Senior research analysts
We empower our investors with focused, best-in-class macro research. Our top-ranked analysts utilize independent processes that provide impartial insights into economic trends, policy actions and political developments.
Specialized research coverage
We publish collaborative, cross-sector research that provides extensive market, industry, and technical research.
The Piper Sandler BioInsights research platform provides in-depth analyses across a diverse range of innovative and emerging therapeutic modalities, novel drug targets and disease states, through monthly thematic reports, expert events, catalyst calendars and more.
News & Insights
Private Company Summit
Growth Frontiers Conference
*SMID cap < $5 billion; data as of August 2022. Source: Thomson Reuters.